Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122532) titled 'Study on the Efficacy of Normobaric Hyperoxia in Surgical Patients with Moyamoya Disease: A Prospective, Single-Center, Randomized Controlled Trial' on April 14.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Henan Provincial People's Hospital
Condition:
Moyamoya Disease
Intervention:
Normobaric Hyperoxia Group:From intraoperative period (after anesthesia induction) to 4 hours postoperatively, patients inhaled 100% oxygen via a non?rebreathing mask at a flow rate of 10 L/min
for intubated patients, the fraction of inspired oxygen (FiO?) was set at 1.0.
Sham Control ...